PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
13-Jul-2022 Caixa Capital Risc leads €5.5M Series A funding round for Zinklar Andrew Lloyd Associates
13-Jul-2022 Zinklar raises €5.5M in Series A to accelerate global rollout of its insights automation platform Andrew Lloyd Associates
12-Jul-2022 ProBioGen Teams Up with Granite Bio for Cell Line Development and GMP Manufacturing Services ProBioGen
12-Jul-2022 AI-powered drug discovery company Healx opens new labs at Chesterford Research Park Healx
12-Jul-2022 HDR UK and Wellcome launch Biomedical Vacation Scholarship Programme 2022 HDR UK
12-Jul-2022 Yposkesi reinforces team with three executive appointments Andrew Lloyd Associates
12-Jul-2022 Anjarium Biosciences appoints experienced industry executives Samantha Vieira as Chief Operating Officer and Nate Massari as Chief Business Officer Anjarium Biosciences
12-Jul-2022 Genmab Major Shareholder Announcement Genmab
12-Jul-2022 Provepharm receives FDA marketing approval in US for BLUDIGO, its indigo carmine injection drug product Andrew Lloyd Associates
12-Jul-2022 MODERNA’S OMICRON-CONTAINING BIVALENT BOOSTER CANDIDATE, mRNA-1273.214, DEMONSTRATES SIGNIFICANTLY HIGHER NEUTRALIZING ANTIBODY RESPONSE AGAINST OMICRON SUBVARIANTS BA.4/5 COMPARED TO CURRENTLY AUTHORIZED BOOSTER MODERNA
12-Jul-2022 Actigen Receives Positive FDA Response for Rare Disease Treatment Actigen
12-Jul-2022 AWAKN LIFE SCIENCES RECEIVES UK STATE FUNDING TO IDENTIFY OPTIMAL PATHWAY TO MARKET IN UK & US FOR ITS LEAD CLINICAL DEVELOPMENT PROGRAM – KETAMINE-ASSISTED THERAPY FOR ALCOHOL USE DISORDER AWAKN LIFE SCIENCES
11-Jul-2022 Brochure available for Biosensors for Medical Wearables Conference 2022 SAE Media Group
11-Jul-2022 ABL partners with KaliVir Immunotherapeutics to advance development of oncolytic viruses Andrew Lloyd Associates
11-Jul-2022 Nosopharm welcomes new members to supervisory board Andrew Lloyd Associates
08-Jul-2022 Alfa Chemistry Commenced Offering Monosubstituted Pyridinium-Based Ionic Liquids Alfa Chemistry
07-Jul-2022 Myrtil Biotechnologies – innovating drug discovery for patients with dilated cardiomyopathy Myrtil Biotechnologies
06-Jul-2022 DelSiTech and Iveric Bio Enter Exclusive Agreement for Development of Sustained Release Zimura® IVERIC bio, Inc.
06-Jul-2022 Network with Johnson & Johnson, Springboard, BSI, AstraZeneca and many more at the Wearable Injectors & Connected Devices Conference SAE Media Group
06-Jul-2022 Thabor Therapeutics secures €2 million in deep tech financing from Bpifrance Andrew Lloyd Associates